The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644 · cited 1×
“Standard methods of meta-analysis were applied to the data to derive composite estimates of relative risk with 95 % confidence limits and tests of heterogeneity (Schlesselman, 1982; Greenland, 1987).”
MethodAntiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Randomised trial of prophylactic daily aspirin in British male doctors
Peto, R., Gray, R., Collins, R., Wheatley, K., Hennekens, C., Jamrozik, K., Warlow, C., Hafner, B., Thompson, E., Norton, S., et al. (1988) · BMJ · doi:10.1136/bmj.296.6618.313 · Cited by 1,166
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., & Hla, T. (1995) · PubMed · Cited by 1,126
McGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Arber, N., Eagle, C. J., Spicak, J., Rácz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061652 · Cited by 975
Graham, D. J., Campen, D., Hui, R., Spence, M., Cheetham, C., Levy, G., Shoor, S., & Ray, W. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17864-7 · Cited by 913
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., & Koki, A. T. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b · Cited by 862
Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., & Takahashi, T. (1998) · PubMed · Cited by 818
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 736
Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff, H. J., Saukkonen, K., Anttila, S. L., Karjalainen, A., Vainio, H., & Ristimaki, A. P. (1998) · PubMed · Cited by 717
Rothman, K. J., Greenland, S., & Lash, T. L. (2008) · Encyclopedia of Quantitative Risk Analysis and Assessment · doi:10.1002/9780470061596.risk0599 · Cited by 706
Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs
Langman, M. J. (1999) · JAMA · doi:10.1001/jama.282.20.1929 · Cited by 686
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
Hwang, D., Byrne, J., Scollard, D., & Levine, E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.455 · Cited by 651
Buckman, S. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.723 · Cited by 590
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Hippisley-Cox, J., & Coupland, C. (2005) · BMJ · doi:10.1136/bmj.330.7504.1366 · Cited by 561
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma
Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D. G., & Mukhtar, H. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000101)42:1<73::aid-pros9>3.0.co;2-g · Cited by 526
Solomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 509
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
Ray, W. A., Stein, C. M., Daugherty, J. R., Hall, K., Arbogast, P. G., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11131-7 · Cited by 503
A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large-Bowel Cancer
Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., & Shapiro, S. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.5.355 · Cited by 501
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 478
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 463
Mamdani, M., Juurlink, D. N., Lee, D. S., Rochon, P. A., Kopp, A., Naglie, G., Austin, P. C., Laupacis, A., & Stukel, T. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16299-5 · Cited by 435
Langman, M. J. S. (2000) · BMJ · doi:10.1136/bmj.320.7250.1642 · Cited by 419
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G. L., Loar, A., Rodabough, R. J., White, E., & McTiernan, A. (2003) · PubMed · Cited by 411
Self-citationHarris, R., Beebe-Donk, J., Doss, H., & Doss, D. (2005) · Oncology Reports · doi:10.3892/or.13.4.559 · Cited by 408
Self-citationCyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
Khuri, F. R., Wu, H., Lee, J. J., Kemp, B. L., Lotan, R., Lippman, S. M., Feng, L., Hong, W. K., & Xu, X. C. (2001) · PubMed · Cited by 406
Aspirin use and chronic diseases: a cohort study of the elderly.
Paganini-Hill, A., Chao, A., Ross, R. K., & Henderson, B. E. (1989) · BMJ · doi:10.1136/bmj.299.6710.1247 · Cited by 396
Solomon, S. D., Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., Arber, N., Levin, B., Meinert, C. L., Martin, B., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.764530 · Cited by 367
García Rodríguez, L. A., & Huerta-Alvarez, C. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00015 · Cited by 359
Nonsteroidal Antiinflammatory Drugs and Breast Cancer
Harris, R. E., Namboodiri, K. K., & Farrar, W. B. (1996) · Epidemiology · doi:10.1097/00001648-199603000-00017 · Cited by 345
Self-citationRisk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
Pinczowski, D., Ekbom, A., Baron, J., Yuen, J., & Adami, H.-O. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90068-x · Cited by 337
Expression of cyclooxygenase-2 in prostate carcinoma
Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J., Yoshimura, N., Hla, T., & Wada, S. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<589::aid-cncr14>3.0.co;2-c · Cited by 335
Ray, W. A., Stein, C. M., Hall, K., Daugherty, J. R., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07370-1 · Cited by 326
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe, L. R., Subbaramaiah, K., Brown, A. M., & Dannenberg, A. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080097 · Cited by 322
A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Jacobs, E. J., Thun, M. J., Bain, E. B., Rodriguez, C., Henley, S. J., & Calle, E. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk132 · Cited by 322
Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., & Takahashi, T. (1999) · PubMed · Cited by 310
Johnsen, S. P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.978 · Cited by 288
Aspirin use, cancer, and polyps of the large bowel
Suh, O., Mettlin, C., & Petrelli, N. J. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d · Cited by 276
Terry, M. B. (2004) · JAMA · doi:10.1001/jama.291.20.2433 · Cited by 271
Smalley, W., Ray, W. A., Daugherty, J., & Griffin, M. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.161 · Cited by 264
Ombardier, C. L. B., Aine, L. O. L., Eicin, A. L. R., Hapiro, D. E. S., Urgos, R. U. B., Avis, B. A. D., Ay, R., Arcos, M. J., Erraz, B. O. F., Awkey, C. H. J. H., et al. (2010) · Cited by 253
Lévesque, L. E., Brophy, J. M., & Zhang, B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00113 · Cited by 249
Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction
Kimmel, S. E., Berlin, J. A., Reilly, M., Jaskowiak, J., Kishel, L., Chittams, J., & Strom, B. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-3-200502010-00005 · Cited by 222
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-27 · Cited by 214
Self-citationAspirin and Nonsteroidal Anti-inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer
Peleg, I. I. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.4.394 · Cited by 213
Helin-Salmivaara, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl053 · Cited by 211
Marrogi, A. J., Travis, W. D., Welsh, J. A., Ma, K., Rahim, H., Tazelaar, H. D., Pairolero, P. C., Trastek, V. F., Jett, J. R., Caporaso, N., et al. (2000) · PubMed · Cited by 205
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
Boland, G. P., Butt, I. S., Prasad, R., Knox, W. F., & Bundred, N. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601534 · Cited by 197
Nonsteroidal antiinflammatory drugs and colorectal cancer
Muscat, J. E., Stellman, S. D., & Wynder, E. L. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7<1847::aid-cncr2820740704>3.0.co;2-# · Cited by 197
White, W. B., West, C. R., Borer, J. S., Gorelick, P. B., Lavange, L., Pan, S. X., Weiner, E., & Verburg, K. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.069 · Cited by 186
Jacobs, E. J., Rodriguez, C., Mondul, A. M., Connell, C. J., Henley, S. J., Calle, E. E., & Thun, M. J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji173 · Cited by 185
Antirheumatic drug use and the risk of acute myocardial infarction
Suissa, S., Bernatsky, S., & Hudson, M. (2006) · Arthritis Care & Research · doi:10.1002/art.22094 · Cited by 184
Prospective Study of Regular Aspirin Use and the Risk of Breast Cancer
Egan, K. M., Stampfer, M. J., Giovannucci, E., Rosner, B. A., & Colditz, G. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.14.988 · Cited by 183
The role of cyclooxygenase-2 in prostate cancer
Kirschenbaum, A., Liu, X.-H., Yao, S., & Levine, A. C. (2001) · Urology · doi:10.1016/s0090-4295(01)01255-9 · Cited by 182
Cyclooxygenase-2 (COX-2) and the Inflammogenesis of Cancer
Harris, R. E. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_4 · Cited by 181
Self-citationAndersohn, F., Suissa, S., & Garbe, E. (2006) · Circulation · doi:10.1161/circulationaha.105.602425 · Cited by 178
Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.
Harris, R. E., Kasbari, S., & Farrar, W. B. (1999) · Oncology Reports · doi:10.3892/or.6.1.71 · Cited by 175
Self-citationSolomon, D. H., Avorn, J., Stürmer, T., Glynn, R. J., Mogun, H., & Schneeweiss, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21887 · Cited by 173
Shiff, S. J., & Rigas, B. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)99999-6 · Cited by 172
Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
Kelley, D. J., Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., Ramonetti, J. T., & Dannenberg, A. J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.4.795 · Cited by 170
Nelson, J. E., & Harris, R. E. (2000) · Oncology Reports · doi:10.3892/or.7.1.169 · Cited by 165
Self-citationHudson, M., Richard, H., & Pilote, L. (2005) · BMJ · doi:10.1136/bmj.330.7504.1370 · Cited by 164
Shiff, S. J., & Rigas, B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.445 · Cited by 164
Chang, Y., Wu, M., Lin, J., & Chen, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8242 · Cited by 158
Wang, W., Bergh, A. R. J., & Damber, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2405 · Cited by 157
Bernatsky, S., Hudson, M., & Suissa, S. (2005) · Rheumatology · doi:10.1093/rheumatology/keh610 · Cited by 154
Friis, S., Sørensen, H. T., McLaughlin, J. K., Johnsen, S. P., Blot, W. J., & Olsen, J. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600760 · Cited by 151
Association between coronary heart disease and cancers of the breast, prostate, and colon.
Neugut, A. I., Rosenberg, D. J., Ahsan, H., Jacobson, J. S., Wahid, N., Hagan, M., Rahman, M. I., Khan, Z. R., Chen, L., Pablos-Méndez, A., et al. (1998) · PubMed · Cited by 142
Moraitis, D., Du, B., Lorenzo, M. S. D., Boyle, J. O., Weksler, B. B., Cohen, E. G., Carew, J. F., Altorki, N. K., Kopelovich, L., Subbaramaiah, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.664.65.2 · Cited by 141
Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status
Marshall, S. F., Bernstein, L., Anton‐Culver, H., Deapen, D., Horn‐Ross, P. L., Mohrenweiser, H. W., Peel, D. A., Pinder, R., Purdie, D. M., Reynolds, P., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji140 · Cited by 135
Inoue, H., Taba, Y., Miwa, Y., Yokota, C., Miyagi, M., & Sasaguri, T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000028816.13582.13 · Cited by 131
Aspirin use and mortality from cancer in a prospective cohort study.
Ratnasinghe, L. D., Graubard, B. I., Kahle, L., Tangrea, J. A., Taylor, P. R., & Hawk, E. (2004) · PubMed · Cited by 124
Cyclooxygenase, NSAIDs, and colorectal cancer
DuBois, R. N., & Smalley, W. E. (1996) · Journal of Gastroenterology · doi:10.1007/bf02358623 · Cited by 119
Motsko, S. P., Rascati, K. L., Busti, A. J., Wilson, J. P., Barner, J. C., Lawson, K. A., & Worchel, J. (2006) · Drug Safety · doi:10.2165/00002018-200629070-00007 · Cited by 115
Shah, A. A., Þjóðleifsson, B., Murray, F. E., Kay, E., Barry, M. C., Sigthorsson, G., Gudjónsson, H., Oddsson, E., Price, A. B., Fitzgerald, D. J., et al. (2001) · Gut · doi:10.1136/gut.48.3.339 · Cited by 107
Gierach, G. L., Lacey, J. V., Schatzkin, A. G., Leitzmann, M. F., Richesson, D. A., Hollenbeck, A. R., & Brinton, L. A. (2008) · Breast Cancer Research · doi:10.1186/bcr2089 · Cited by 106
Marrogi, A. J., Pass, H. I., Khan, M., Metheny‐Barlow, L. J., Harris, C. C., & Gerwin, B. I. (2000) · PubMed · Cited by 105
Rahme, E., Barkun, A. N., Toubouti, Y. M., & Bardou, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00880-1 · Cited by 104
Abraham, N. S., EL‐SERAG, H. B., Hartman, C. M., Richardson, P., & Deswal, A. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03292.x · Cited by 103
IL6 genotypes and colon and rectal cancer
Slattery, M. L., Wolff, R. K., Herrick, J. S., Caan, B. J., & Potter, J. D. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9049-x · Cited by 103
Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
Reeves, M. J., Newcomb, P. A., Trentham‐Dietz, A., Storer, B. E., & Remington, P. (1996) · PubMed · Cited by 100
Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs and the Risk of Ischemic Stroke
Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2006) · Stroke · doi:10.1161/01.str.0000226642.55207.94 · Cited by 98
Aspirin use in relation to risk of prostate cancer.
Leitzmann, M. F., Stampfer, M. J., Ma, J., Chan, J. M., Colditz, G. A., Willett, W. C., & Giovannucci, E. L. (2002) · PubMed · Cited by 98
Vecchia, C. L., Negri, E., Franceschi, S., Conti, E., Montella, M., Giacosa, A., Falcini, F., & Decarli, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.444 · Cited by 97
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer
Rahme, E., Ghosn, J., Dasgupta, K., Rajan, R., & Hudson, M. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-159 · Cited by 96
Cheng, A. S. L., Chan, H. L.-Y., Leung, W. K., To, K. F., Go, M. Y., Chan, J. Y., Liew, C.-T., & Sung, J. J. �. (2004) · Modern Pathology · doi:10.1038/modpathol.3800196 · Cited by 95
Nonaspirin NSAIDs, Cyclooxygenase 2 Inhibitors, and the Risk for Stroke
Roumie, C. L., Mitchel, E. F., Kaltenbach, L. A., Arbogast, P. G., Gideon, P. S., & Griffin, M. R. (2008) · Stroke · doi:10.1161/strokeaha.107.508549 · Cited by 92
Ji, Y., Xu, Q., & Schmedtje, J. F. (1998) · Circulation Research · doi:10.1161/01.res.83.3.295 · Cited by 92
Barnes, N. L. P., Haywood, P., Flint, P., Knox, W. F., & Bundred, N. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602932 · Cited by 88
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.328 · Cited by 88
Self-citationMicrosomal prostaglandin E2 synthase‐1 in breast cancer: a potential target for therapy
Mehrotra, S., Morimiya, A., Agarwal, B., Konger, R. L., & Badve, S. (2005) · The Journal of Pathology · doi:10.1002/path.1907 · Cited by 87
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-237 · Cited by 84
Self-citationAspirin and lung cancer in women
Akhmedkhanov, A., Toniolo, P. G., Zeleniuch‐Jacquotte, A., Koenig, K. L., & Shore, R. E. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600370 · Cited by 83
Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species
Jaimes, E. A., Tian, R.-X., Pearse, D. D., & Raij, L. R. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00670.x · Cited by 83
Zhang, Y., Coogan, P. F., Palmer, J. R., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi182 · Cited by 82
Soumaoro, L. T., Uetake, H., Takagi, Y., Iida, S., Higuchi, T., Yasuno, M., Enomoto, M., & Sugihara, K. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0247-x · Cited by 75
Inverse Association between Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer
Rodríguez, L. A. G., & González‐Pérez, A. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.649.13.4 · Cited by 74
Slattery, M. L., Curtin, K., Baumgartner, R., Sweeney, C., Byers, T., Giuliano, A. R., Baumgartner, K. B., & Wolff, R. K. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0667 · Cited by 73
Müller, N., Riedel, M., & Schwarz, M. J. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832682 · Cited by 71 · cited 1×
“…(Singh et al., 2004), hepatitis viruses (Cheng et al., 2004), and the Epstein Barr virus (Kaul et al., 2006), hypoxia (Ji et al., 1998), hormones (Diaz-Cruz and Brueggemeier, 2006), neurotransmitters (Muller et al., 2004), shear stress (Inoue et al., 2002), and endotoxins (Bezugla et al., 2006).”
BackgroundKhan, K. N. M., Masferrer, J. L., Woerner, B. M., Soslow, R. A., & Koki, A. T. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750313405 · Cited by 71
Harris, R. E., Robertson, F. M., Abou‐Issa, H., Farrar, W. B., & Brueggemeier, R. W. (1999) · Medical Hypotheses · doi:10.1054/mehy.1998.0009 · Cited by 70
Self-citationDosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
Perron, L., Bairati, I., Moore, L., & Meyer, F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11250 · Cited by 68
Association of Regular Aspirin Use and Breast Cancer Risk
Swede, H., Mirand, A. L., Menezes, R. J., & Moysich, K. B. (2005) · Oncology · doi:10.1159/000084818 · Cited by 67
Bezugla, Y., Kolada, A., Kamionka, S., Bernard, B., Scheibe, R., & Dieter, P. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.11.001 · Cited by 63
Mahipal, A., Anderson, K. E., Limburg, P. J., & Folsom, A. R. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0674 · Cited by 62
Moorman, P. G., Grubber, J. M., Millikan, R. C., & Newman, B. M. (2003) · Cancer Causes & Control · doi:10.1023/b:caco.0000007973.59863.66 · Cited by 61
NSAID use and breast cancer risk in the VITAL cohort
Ready, A., Velicer, C. M., McTiernan, A., & White, E. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9665-x · Cited by 61
Song, S., Lippman, S. M., Zou, Y., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208992 · Cited by 60
van der Linden, M. W., van der Bij, S., Welsing, P. M. J., Kuipers, E. J., & Herings, R. M. C. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.087254 · Cited by 60
Perrone, G., Santini, D., Vincenzi, B., Zagami, M., Cesa, A. L., Bianchi, A., Altomare, V., Primavera, A., Battista, C., Vetrani, A., et al. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02132.x · Cited by 57
FRIEDMAN, G. D., Coates, A. O., Potter, J. D., & Slattery, M. L. (1998) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199803/04)7:2<99::aid-pds320>3.0.co;2-0 · Cited by 57
Nonsteroidal anti‐inflammatory drugs and risk of lung cancer
Hernández–Dı́az, S., & Rodríguez, L. A. G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22514 · Cited by 56
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
Friis, S., Thomassen, L., Sørensen, H. T., Tjønneland, A. M., Overvad, K., Cronin-Fenton, D. P., Vogel, U. B., McLaughlin, J. K., Blot, W. J., & Olsen, J. H. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282b6fd55 · Cited by 56
Shen, J., Gammon, M. D., Terry, M. B., Teitelbaum, S. L., Neugut, A. I., & Santella, R. M. (2006) · Breast Cancer Research · doi:10.1186/bcr1629 · Cited by 56
Huang, W.-F., Hsiao, F., Wen, Y., & Tsai, Y.-W. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.009 · Cited by 55
Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women
Dyke, A. L. V., Coté, M. L., Prysak, G. M., Claeys, G. B., Wenzlaff, A. S., & Schwartz, A. G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0517 · Cited by 55
Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings
Kirsh, V. A., Kreiger, N., Cotterchio, M., Sloan, M., & Theis, B. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm216 · Cited by 52
Coogan, P. F., Rosenberg, L. A., Louik, C., Zauber, A. G., Stolley, P. D., Strom, B. L., & Shapiro, S. (2000) · Cancer Causes & Control · doi:10.1023/a:1008931708716 · Cited by 51
Kaul, R., Verma, S. C., Murakami, M., Lan, K., Choudhuri, T., & Robertson, E. S. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1321-1331.2006 · Cited by 50
Aspirin use and lung cancer in men
Holick, C. N., Michaud, D. S., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601343 · Cited by 48
Sansbury, L. B., Millikan, R. C., Schroeder, J. C., Moorman, P. G., North, K. E., & Sandler, R. S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi248 · Cited by 48
Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer.
Konturek, P. C., Hartwich, A., Żuchowicz, M., et al. (2000) · PubMed · Cited by 47
Impact of NSAIDS on Mortality and the Effect of Preexisting Coronary Artery Disease in US Veterans
Lee, T. A., Bartle, B., & Weiss, K. B. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.003 · Cited by 47
Velentgas, P., West, W., Cannuscio, C. C., Watson, D. J., & Walker, A. M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1192 · Cited by 45
Gallicchio, L. M., Visvanathan, K., Burke, A. E., Hoffman, S. C., & Helzlsouer, K. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22656 · Cited by 44
EPIDEMIOLOGIC-STUDY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BREAST-CANCER
HARRIS, R., Namboodiri, K. K., & Farrar, W. (1995) · Oncology Reports · doi:10.3892/or.2.4.591 · Cited by 44
Self-citationAspirin and Colorectal Cancer: The Leisure World Cohort Revisited
Paganini‐Hill, A. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1020 · Cited by 37
Díaz‐Cruz, E. S., & Brueggemeier, R. W. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006776930873 · Cited by 36
Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan
Huang, W.-F., Hsiao, F., Tsai, Y., Wen, Y., & Shih, Y. (2006) · Drug Safety · doi:10.2165/00002018-200629030-00009 · Cited by 34
Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency
Feskanich, D., Bain, C., Chan, A. T., Pandeya, N., Speizer, F. E., & Colditz, G. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603996 · Cited by 32
Hayes, J., Anderson, K. E., & Folsom, A. R. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0172 · Cited by 32
Cyclooxygenase‐2 inhibitors and coronary occlusion – exploring dose–response relationships
McGettigan, P., Han, P., & Henry, D. A. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02660.x · Cited by 31
The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women
Allison, M., Garland, C., Chlebowski, R. T., Criqui, M. H., Langer, R., Wu, L., Roy, H. K., McTiernan, A., & Kuller, L. H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj250 · Cited by 31
Nasir, A., Kaiser, H. E., Boulware, D. C., Hakam, A., Zhao, H., Yeatman, T. J., Barthel, J. S., & Coppola, D. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.005 · Cited by 29
Spalding, W. M., Reeves, M. J., & Whelton, A. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249930.01907.db · Cited by 25
Singh, A., Sharma, H., Salhan, S., Gupta, S. D., Bhatla, N., Jain, S. K., & Singh, N. (2004) · Pathobiology · doi:10.1159/000081727 · Cited by 24
Risk of ischaemic cardiovascular events from selective cyclooxygenase‐2 inhibitors in osteoarthritis
Cunnington, M. C., Webb, D., Qizilbash, N., Blum, D., Mander, A., Funk, M. J., & Weil, J. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1590 · Cited by 24
COX‐2 selective non‐steroidal anti‐inflammatory drugs and cardiovascular disease
Ray, W. A., MacDonald, T. M., Solomon, D. H., Graham, D. J., & Avorn, J. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.798 · Cited by 24
Rahme, E., Watson, D. J., Kong, S. X., Toubouti, Y. M., & LeLorier, J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1339 · Cited by 23
Koki, A. T., Leahy, K. M., Harmon, J. M., & Masferrer, J. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_12 · Cited by 21
Historical Aspects of COX-2: Cloning and Characterization of the cDNA, Protein and Gene
Herschman, H. R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_2 · Cited by 21
Zhuang, Z., Tsao, S., Deng, W., Wang, J., Xia, H. H., He, H., Feng, H., Wang, L., Gu, Q., Lam, S. G., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05509.x · Cited by 20
Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA
Chang, Y. E., Putzer, K., Ren, L., Kaboord, B. J., Chance, T. W., Qoronfleh, M. W., & Jakobi, R. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20568 · Cited by 18
Cyclooxygenase-2 Blockade in Cancer Prevention and Therapy: Widening the Scope of Impact
Harris, R. E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-302-x:341 · Cited by 9
Self-citationDietary Fatty Acids, COX-2 Blockade, and Carcinogenesis
Karmali, R. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_1 · Cited by 6
The Role of Cyclooxygenase-2 in the Prevention and Therapy of Lung Cancer
Schuller, H. M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_7 · Cited by 5
Nonsteroidal Anti-Inflammatory Drugs, Prostaglandins, and Apc-Driven Intestinal Tumorigenesis
Whelan, J., & McEntee, M. F. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_8 · Cited by 5
Cited by
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Stromal cells in tumor microenvironment and breast cancer
Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., & Wang, J. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9415-3 · Cited by 671
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
Metadata
- Authors
- Harris, R. E.
- Venue
- Inflammopharmacology
- Published
- 2009-04
- Volume
- 17
- Issue
- 2
- Pages
- 55-67
- ISSN
- 0925-4692 (ISSN-L)
- 1568-5608
- OpenAlex
- W2082764531
- Cited by
- 329
- References
- 163
- FWCI
- 19.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.